Citations (65)
Keep up to date with the latest research on this topic with citation updates for this article.
Read on this site (3)
Delia D’Avola & Gloria Gonzalez Aseguinolaza. (2016) Prospect and progress of gene therapy in acute intermittent porphyria. Expert Opinion on Orphan Drugs 4:7, pages 711-717.
Read now
Read now
Elena Pischik & Raili Kauppinen. (2015) An update of clinical management of acute intermittent porphyria. The Application of Clinical Genetics 8, pages 201-214.
Read now
Read now
Pauline Harper & Eliane Sardh. (2014) Management of acute intermittent porphyria. Expert Opinion on Orphan Drugs 2:4, pages 349-368.
Read now
Read now
Articles from other publishers (62)
Manisha Balwani, Siobán Keel, Peter Meissner, Mark Sonderup, Penelope Stein & Makiko Yasuda. (2024) Case‐based discussion of the acute hepatic porphyrias: Updates on pathogenesis, diagnosis and management. Liver International.
Crossref
Crossref
Yutaka Horie, Yuka Yasuoka & Tomohide Adachi. (2023) Clinical features of acute attacks, chronic symptoms, and long-term complications among patients with acute hepatic porphyria in Japan: a real-world claims database study. Orphanet Journal of Rare Diseases 18:1.
Crossref
Crossref
Oluwashanu Balogun & Kari Nejak-Bowen. (2023) The Hepatic Porphyrias: Revealing the Complexities of a Rare Disease. Seminars in Liver Disease 43:04, pages 446-459.
Crossref
Crossref
Mattias Lissing, Axel Wester, Daphne Vassiliou, Ylva Floderus, Pauline Harper, Eliane Sardh & Staffan Wahlin. (2023) Porphyrin precursors and risk of primary liver cancer in acute intermittent porphyria: A case–control study of 188 patients. Journal of Inherited Metabolic Disease 46:6, pages 1186-1194.
Crossref
Crossref
Jose Malagon‐Rangel, Jose Gabriel Solis, Luis Fernando Zavala‐Jonguitud, Martín Roberto Basile‐Alvarez & Andrea Malagon‐Liceaga. (2023) A novel mutation c.457C > T p.Q153 in the HMBS gene in a Mexican woman with acute intermittent porphyria. Clinical Case Reports 11:11.
Crossref
Crossref
Ängla Mantel, Daphne Vassiliou, Mattias Lissing, Olof Stephansson, Staffan Wahlin & Eliane Sardh. (2023)
Maternal and fetal outcomes in acute hepatic porphyria:
A Swedish National Cohort S
tudy
. Journal of Inherited Metabolic Disease 46:4, pages 675-686.
Crossref
Crossref
Esma Z Kizilaslan, Nitin M Ghadge, Andrea Martinez, Michelle Bass, Rahul Winayak, Midhun Mathew, Rutvi Amin, Muhammad Khan & Nadeem Kizilbash. (2023) Acute Intermittent Porphyria’s Symptoms and Management: A Narrative Review. Cureus.
Crossref
Crossref
Paulo Victor Sgobbi Souza, Gliciane Afonso, Wladimir Bocca Vieira de Rezende Pinto, Paulo de Lima Serrano, Bruno de Mattos Lombardi Badia, Igor Braga Farias, Ana Carolina dos Santos Jorge, Roberta Ismael Lacerda Machado, Icaro França Navarro Pinto, Glenda Barbosa Barros, Helvia Bertoldo de Oliveira, Samia Rogatis Calil, Cibele Franz & Acary Souza Bulle Oliveira. (2023) Brazilian registry of patients with porphyria: REBRAPPO study. Orphanet Journal of Rare Diseases 18:1.
Crossref
Crossref
Bruce Wang, Herbert L. Bonkovsky, Joseph K. Lim & Manisha Balwani. (2023) AGA Clinical Practice Update on Diagnosis and Management of Acute Hepatic Porphyrias: Expert Review. Gastroenterology 164:3, pages 484-491.
Crossref
Crossref
Isabel Solares, Daniel Jericó, Karol M. Córdoba, Montserrat Morales-Conejo, Javier Ena, Rafael Enríquez de Salamanca & Antonio Fontanellas. (2022) Understanding Carbohydrate Metabolism and Insulin Resistance in Acute Intermittent Porphyria. International Journal of Molecular Sciences 24:1, pages 51.
Crossref
Crossref
Marthe S. Christie, Mikko Laitaoja, Aasne K. Aarsand, Juha P. Kallio & Helene J. Bustad. (2022) Characterisation of a common hotspot variant in acute intermittent porphyria sheds light on the mechanism of hydroxymethylbilane synthase function. FEBS Open Bio 12:12, pages 2136-2146.
Crossref
Crossref
Seyma Eroglu & Ilhan Birsenogul. (2022) Delirium with delayed diagnosis of hereditary coproporphyria. Clinical Case Reports 10:6.
Crossref
Crossref
Eliane Sardh & Pauline Harper. (2022) RNAi therapy with givosiran significantly reduces attack rates in acute intermittent porphyria. Journal of Internal Medicine 291:5, pages 593-610.
Crossref
Crossref
Yuanxiang Hu, Weihao Li, Ninglin Kang, Liyan Ma, Qing Teng, Guiling Mo, Jiahong Wu, Xinyang Wang, Renjie Bi & Songyun Zhang. (2021) Identification and molecular analysis of 17 novel variants of hydroxymethylbilane synthase in Chinese patients with acute intermittent porphyria. Clinical Genetics 101:1, pages 116-121.
Crossref
Crossref
Juan Buendía-Martínez, María Barreda-Sánchez, Lidya Rodríguez-Peña, María Juliana Ballesta-Martínez, Vanesa López-González, María José Sánchez-Soler, Ana Teresa Serrano-Antón, María Elena Pérez-Tomás, Remedios Gil-Ferrer, Francisco Avilés-Plaza, Guillermo Glover-López, Carmen Carazo-Díaz & Encarna Guillén-Navarro. (2021) Health impact of acute intermittent porphyria in latent and non-recurrent attacks patients. Orphanet Journal of Rare Diseases 16:1.
Crossref
Crossref
Hung-Chou Kuo, Chia-Ni Lin & Yi-Fen Tang. (2021) Prophylactic Heme Arginate Infusion for Acute Intermittent Porphyria. Frontiers in Pharmacology 12.
Crossref
Crossref
Karl E. Anderson, Raynah Lobo, Denise Salazar, Mary Schloetter, Gary Spitzer, Amy L. White, Randolph M. Young, Herbert L. Bonkovsky, Elizabeth L. Frank, Jordanna Mora & Silvia Tortorelli. (2021) Biochemical Diagnosis of Acute Hepatic Porphyria: Updated Expert Recommendations for Primary Care Physicians. The American Journal of the Medical Sciences 362:2, pages 113-121.
Crossref
Crossref
Carl Michael Baravelli, Aasne Karine Aarsand, Sverre Sandberg & Mette Christophersen Tollånes. (2020) Sick leave, disability, and mortality in acute hepatic porphyria: a nationwide cohort study. Orphanet Journal of Rare Diseases 15:1.
Crossref
Crossref
Liyan MaYu TianChenxing PengYiran ZhangSongyun Zhang. (2020) Recent advances in the epidemiology and genetics of acute intermittent porphyria. Intractable & Rare Diseases Research 9:4, pages 196-204.
Crossref
Crossref
Yuelin MaQing TengYiran ZhangSongyun Zhang. (2020) Acute intermittent porphyria: focus on possible mechanisms of acute and chronic manifestations. Intractable & Rare Diseases Research 9:4, pages 187-195.
Crossref
Crossref
Mladen Knotek, Rafaela Novak, Alemka Jaklin-Kekez & Anna Mrzljak. (2020) Combined liver-kidney transplantation for rare diseases. World Journal of Hepatology 12:10, pages 722-737.
Crossref
Crossref
K. Baumann & R. Kauppinen. (2020) Penetrance and predictive value of genetic screening in acute porphyria. Molecular Genetics and Metabolism 130:1, pages 87-99.
Crossref
Crossref
Marte H. Hammersland, Aasne K. Aarsand, Sverre Sandberg & Janice Andersen. (2019) Self-efficacy and self-management strategies in acute intermittent porphyria. BMC Health Services Research 19:1.
Crossref
Crossref
Olivia Bronisch, Thomas Stauch, Thomas Haverkamp, Maria K. Beykirch & Petro E. Petrides. (2019) Acute porphyrias: a German monocentric study of the biochemical, molecular genetic, and clinical data of 62 families. Annals of Hematology 98:12, pages 2683-2691.
Crossref
Crossref
Herbert L. Bonkovsky, Natalia Dixon & Sean Rudnick. (2019) Pathogenesis and clinical features of the acute hepatic porphyrias (AHPs). Molecular Genetics and Metabolism 128:3, pages 213-218.
Crossref
Crossref
Elin Storjord, Jim A. Dahl, Anne Landsem, Judith K. Ludviksen, Marlene B. Karlsen, Bård O. Karlsen & Ole-L. Brekke. (2019) Lifestyle factors including diet and biochemical biomarkers in acute intermittent porphyria: Results from a case-control study in northern Norway. Molecular Genetics and Metabolism 128:3, pages 254-270.
Crossref
Crossref
Katell Peoc'h, Hana Manceau, Zoubida Karim, Staffan Wahlin, Laurent Gouya, Hervé Puy & Jean-Charles Deybach. (2019) Hepatocellular carcinoma in acute hepatic porphyrias: A Damocles Sword. Molecular Genetics and Metabolism 128:3, pages 236-241.
Crossref
Crossref
Bruce Wang, Sean Rudnick, Brent Cengia & Herbert L. Bonkovsky. (2018) Acute Hepatic Porphyrias: Review and Recent Progress. Hepatology Communications 3:2, pages 193-206.
Crossref
Crossref
Lei Jiang, Pedro Berraondo, Daniel Jericó, Lin T. Guey, Ana Sampedro, Andrea Frassetto, Kerry E. Benenato, Kristine Burke, Eva Santamaría, Manuel Alegre, Álvaro Pejenaute, Mayur Kalariya, William Butcher, Ji-Sun Park, Xuling Zhu, Staci Sabnis, E. Sathyajith Kumarasinghe, Timothy Salerno, Matthew Kenney, Christine M. Lukacs, Matías A. Ávila, Paolo G. V. Martini & Antonio Fontanellas. (2018) Systemic messenger RNA as an etiological treatment for acute intermittent porphyria. Nature Medicine 24:12, pages 1899-1909.
Crossref
Crossref
Amy Simon, Farrah Pompilus, William Querbes, Alex Wei, Sara Strzok, Craig Penz, Desiree Lyon Howe, Jessica R. Hungate, Jae B. Kim, Sonalee Agarwal & Patrick Marquis. (2018) Patient Perspective on Acute Intermittent Porphyria with Frequent Attacks: A Disease with Intermittent and Chronic Manifestations. The Patient - Patient-Centered Outcomes Research 11:5, pages 527-537.
Crossref
Crossref
Rochus A. Neeleman, Margreet A. E. M. Wagenmakers, Rita H. Koole‐Lesuis, G. Sophie Mijnhout, J. H. Paul Wilson, Edith C. H. Friesema & Janneke G. Langendonk. (2018) Medical and financial burden of acute intermittent porphyria. Journal of Inherited Metabolic Disease 41:5, pages 809-817.
Crossref
Crossref
Satish V. Khadilkar, Rakhil S. Yadav & Bhagyadhan A. PatelSatish V. Khadilkar, Rakhil S. Yadav & Bhagyadhan A. Patel. 2018. Neuromuscular Disorders. Neuromuscular Disorders
493
502
.
Daniel A. Jaramillo-Calle & Daniel C. Aguirre Acevedo. 2019. JIMD Reports, Volume 44. JIMD Reports, Volume 44
65
72
.
Manisha Balwani, Bruce Wang, Karl E. Anderson, Joseph R. Bloomer, D. Montgomery Bissell, Herbert L. Bonkovsky, John D. Phillips & Robert J. Desnick. (2017) Acute hepatic porphyrias: Recommendations for evaluation and long‐term management. Hepatology 66:4, pages 1314-1322.
Crossref
Crossref
C. M. Baravelli, S. Sandberg, A. K. Aarsand, R. M. Nilsen & M. C. Tollånes. (2017) Acute hepatic porphyria and cancer risk: a nationwide cohort study. Journal of Internal Medicine 282:3, pages 229-240.
Crossref
Crossref
Penelope E. Stein, Michael N. Badminton & David C. Rees. (2016) Update review of the acute porphyrias. British Journal of Haematology 176:4, pages 527-538.
Crossref
Crossref
Brenden Chen, Constanza Solis-Villa, Jörg Hakenberg, Wanqiong Qiao, Ramakrishnan R. Srinivasan, Makiko Yasuda, Manisha Balwani, Dana Doheny, Inga Peter, Rong Chen & Robert J. Desnick. (2016)
Acute Intermittent Porphyria: Predicted Pathogenicity of
HMBS
Variants Indicates Extremely Low Penetrance of the Autosomal Dominant Disease
. Human Mutation 37:11, pages 1215-1222.
Crossref
Crossref
Delia D’Avola, Esperanza López-Franco, Bruno Sangro, Astrid Pañeda, Nadina Grossios, Irene Gil-Farina, Alberto Benito, Jaap Twisk, María Paz, Juan Ruiz, Manfred Schmidt, Harald Petry, Pauline Harper, Rafael Enríquez de Salamanca, Antonio Fontanellas, Jesús Prieto & Gloria González-Aseguinolaza. (2016) Phase I open label liver-directed gene therapy clinical trial for acute intermittent porphyria. Journal of Hepatology 65:4, pages 776-783.
Crossref
Crossref
Martin Cederlöf, Sarah E. Bergen, Henrik Larsson, Mikael Landén & Paul Lichtenstein. (2018) Acute intermittent porphyria: Comorbidity and shared familial
risks with schizophrenia and bipolar disorder in Sweden. British Journal of Psychiatry 207:6, pages 556-557.
Crossref
Crossref
A. Ahangari, T. Bäckström, E. Innala, C. Andersson & S. Turkmen. (2015) Acute intermittent porphyria symptoms during the menstrual cycle. Internal Medicine Journal 45:7, pages 725-731.
Crossref
Crossref
Vaithamanithi‐Mudumbai Sadagopa Ramanujam & Karl Elmo Anderson. (2015) Porphyria Diagnostics—Part 1: A Brief Overview of the Porphyrias. Current Protocols in Human Genetics 86:1.
Crossref
Crossref
Zhaohui Yin, Staffan Wahlin, Ewa C. S. Ellis, Pauline Harper, Bo-Göran Ericzon & Greg Nowak. (2014) Hepatocyte Transplantation Ameliorates the Metabolic Abnormality in a Mouse Model of Acute Intermittent Porphyria. Cell Transplantation 23:9, pages 1153-1162.
Crossref
Crossref
S. Nia. (2014) Psychiatric signs and symptoms in treatable inborn errors of metabolism. Journal of Neurology 261:S2, pages 559-568.
Crossref
Crossref
Mira Mykletun, Aasne Karine Aarsand, Egil Støle, Jørild Haugen Villanger, Mette Christophersen Tollånes, Carl Baravelli & Sverre Sandberg. (2014) Porfyrisykdommer i Norge. Tidsskrift for Den norske legeforening 134:8, pages 831-835.
Crossref
Crossref
Joanne T Marsden & David C Rees. (2014) Urinary excretion of porphyrins, porphobilinogen and δ-aminolaevulinic acid following an attack of acute intermittent porphyria. Journal of Clinical Pathology 67:1, pages 60-65.
Crossref
Crossref
Jennifer A. Tracy & P. James B. Dyck. 2014. Neurologic Aspects of Systemic Disease Part II. Neurologic Aspects of Systemic Disease Part II
839
849
.
George Elder, Pauline Harper, Michael Badminton, Sverre Sandberg & Jean‐Charles Deybach. (2012) The incidence of inherited porphyrias in Europe. Journal of Inherited Metabolic Disease 36:5, pages 849-857.
Crossref
Crossref
Gregori Casals, Josep Marcos, Óscar J. Pozo, Paula Aguilera, Carmen Herrero & Jordi To-Figueras. (2013) Gas chromatography–mass spectrometry profiling of steroids in urine of patients with acute intermittent porphyria. Clinical Biochemistry 46:9, pages 819-824.
Crossref
Crossref
S D Whatley & M N Badminton. (2013) Role of genetic testing in the management of patients with inherited porphyria and their families. Annals of Clinical Biochemistry: International Journal of Laboratory Medicine 50:3, pages 204-216.
Crossref
Crossref
EVA INNALA, TORBJÖRN BÄCKSTRÖM, INGER SUNDSTRÖM POROMAA, CHRISTER ANDERSSON & MARIE BIXO. (2012) Women with acute intermittent porphyria have a defect in 5α‐steroid production during the menstrual cycle. Acta Obstetricia et Gynecologica Scandinavica 91:12, pages 1445-1452.
Crossref
Crossref
Elizabeth Anyaegbu, Michael Goodman, Sun-Young Ahn, Mathula Thangarajh, Michael Wong & Marwan Shinawi. (2011) Acute Intermittent Porphyria. Journal of Child Neurology 27:7, pages 917-921.
Crossref
Crossref
Mette C Tollånes, Aasne K Aarsand, Jørild Haugen Villanger, Egil Støle, Jean-Charles Deybach, Joanne Marsden, Jordi To-Figueras & Sverre Sandberg. (2012) Establishing a network of specialist Porphyria centres - effects on diagnostic activities and services. Orphanet Journal of Rare Diseases 7:1, pages 93.
Crossref
Crossref
Cindy S.-Y. Lin, Ming-Jen Lee, Susanna B. Park & Matthew C. Kiernan. (2011) Purple pigments: The pathophysiology of acute porphyric neuropathy. Clinical Neurophysiology 122:12, pages 2336-2344.
Crossref
Crossref
Richard J. Hift, Stig Thunell & Atle Brun. (2011) Drugs in porphyria: From observation to a modern algorithm-based system for the prediction of porphyrogenicity. Pharmacology & Therapeutics 132:2, pages 158-169.
Crossref
Crossref
E. Innala & C. Andersson. (2011) Reply to Letter to the Editor from Prof Viroj Wiwanitkit, Bankok, Thailand. Journal of Internal Medicine 270:4, pages 397-397.
Crossref
Crossref
E. Innala & C. Andersson. (2011) Screening for hepatocellular carcinoma in acute intermittent porphyria: a 15-year follow-up in northern Sweden. Journal of Internal Medicine 269:5, pages 538-545.
Crossref
Crossref
A. González Estrada, S. García-Morillo, L. Gómez Morales & P. Stiefel García-Junco. (2011) Chronic Elevation of Liver Enzymes in Acute Intermittent Porphyria Initially Misdiagnosed as Autoimmune Hepatitis. International Journal of Hepatology 2011, pages 1-3.
Crossref
Crossref
Tomoko Masuda, Rie Ota, Takao Ando, Naoto Maeda, Yutaka Horie, Toshiro Yoshimura, Masakatsu Motomura & Atsushi Kawakami. (2011) False-Positive Accumulation of Metaiodobenzylguanidine in a Case with Acute Intermittent Porphyria. Internal Medicine 50:9, pages 1029-1032.
Crossref
Crossref
Marko Siegesmund, Anne-Moniek van Tuyll van Serooskerken, Pamela Poblete-Gutiérrez & Jorge Frank. (2010) The acute hepatic porphyrias: Current status and future challenges. Best Practice & Research Clinical Gastroenterology 24:5, pages 593-605.
Crossref
Crossref
Maria Domenica Cappellini, Valentina Brancaleoni, Giovanna Graziadei, Dario Tavazzi & Elena Di Pierro. (2010) Porphyrias at a glance: diagnosis and treatment. Internal and Emergency Medicine 5:S1, pages 73-80.
Crossref
Crossref
Staffan Wahlin, Pauline Harper, Eliane Sardh, Christer Andersson, Dan EH Andersson & Bo-Göran Ericzon. (2009) Combined liver and kidney transplantation in acute intermittent porphyria. Transplant International 23:6, pages e18-e21.
Crossref
Crossref
Hervé Puy, Laurent Gouya & Jean-Charles Deybach. (2010) Porphyrias. The Lancet 375:9718, pages 924-937.
Crossref
Crossref